A skin card volume re accelerated and strong cost management results ... As anticipated bio formal revenue was down materially in the period is made to the Bio forma business in Q2 and leading ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company said its lead product candidate ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...

BofA notes that AstraZeneca (AZN) shares are down greater than 10% in the last few days on the back of China concerns around the ongoing ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

A fraud investigation linked to AstraZeneca (NASDAQ:AZN) has expanded to several government agencies, implicating dozens of senior executives at the company as of last week, Shanghai-based business ...

Polling day begins in earnest, as US citizens vote to elect either Kamala Harris or Donald Trump to the premier spot, as final polls predict a razor finish.